Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

被引：0
|
作者：
Shimizu, Hiroaki [1 ]
Mukae, Junichi [1 ]
Shingai, Naoki [1 ]
Toya, Takashi [1 ]
Najima, Yuho [2 ]
Kobayashi, Takeshi [1 ]
Hatsumi, Nahoko [3 ]
Takada, Satoru [3 ]
Handa, Hiroshi [4 ]
Haraguchi, Kyoko [5 ]
Okuyama, Yoshiki [5 ]
Sakamaki, Hisashi [1 ]
Ohashi, Kazuteru [1 ]
Doki, Noriko [1 ]
机构：
[1] Tokyo Metropolitan Canc & Infect Dis Ctr, Komagome Hosp, Div Hematol, Tokyo, Japan
[2] Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan
[3] Saiseikai Maebashi Hosp, Leukemia Res Ctr, Gunma, Japan
[4] Gunma Univ Hosp, Dept Hematol, Maebashi, Gumma, Japan
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Transfus & Cell Therapy, Tokyo, Japan
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-152621
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3380
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia
    S Lee
    MS Tallman
    MM Oken
    PA Cassileth
    JM Bennett
    PH Wiernik
    JM Rowe
    Leukemia, 2000, 14 : 1345 - 1348
  • [32] The prognostic Relevance of measurable Residual Disease in Patients with acute myeloid Leukemia receiving allogeneic Stem Cell Transplantation in first or second morphological Remission
    Jentzsch, M.
    Bischof, L.
    Backhaus, D.
    Brauer, D.
    Schulz, J.
    Franke, G. -N
    Vucinic, V.
    Niederwieser, D.
    Platzbecker, U.
    Schwind, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 183 - 183
  • [33] Prognostic index for adult patients with acute myeloid leukemia in first relapse
    Breems, DA
    Van Putten, WLJ
    Huijgens, PC
    Ossenkoppele, GJ
    Verhoef, GEG
    Verdonck, LF
    Vellenga, E
    De Greef, G
    Jacky, E
    Van der Lelie, J
    Boogaerts, MA
    Löwenberg, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 1969 - 1978
  • [34] Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia
    Araki, Daisuke
    Othus, Megan
    Walter, Roland B.
    Sandhu, Vicky
    Sandmaier, Brenda M.
    Becker, Pamela S.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    HAEMATOLOGICA, 2015, 100 (07) : E254 - E256
  • [35] Significance of Persistent Cytogenetic Abnormalities on Myeloablative Allogeneic Stem Cell Transplantation in First Complete Remission
    Oran, Betul
    Popat, Uday
    Rondon, Gabriella
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Abruzzo, Lynn
    Andersson, Borje S.
    Bashir, Qaiser
    Chen, Julianne
    Kebriaei, Partow
    Khouri, Issa F.
    Koca, Ebru
    Qazilbash, Muzaffar H.
    Champlin, Richard
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : 214 - 220
  • [36] Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission
    Pasvolsky, Oren
    Saliba, Rima M.
    Ledesma, Celina
    Popat, Uday R.
    Alousi, Amin
    Olson, Amanda
    Oran, Betul
    Hosing, Chitra
    Bashir, Qaiser
    Qazilbash, Muzaffar H.
    Short, Nicholas J.
    Ravandi, Farhad
    Champlin, Richard
    Shpall, Elizabeth J.
    Kebriaei, Partow
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (02) : E35 - E37
  • [37] RELAPSE INCIDENCE POST UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION: FROM THE ALWP OF THE EBMT
    Nagler, Arnon
    Ngoya, Maud
    Galimard, Jacques-Emmanuel
    Labopin, Myriam
    Blau, Igor Wolfgang
    Kroeger, Nicolaus
    Gedde-Dahl, Tobias
    Schroeder, Thomas
    Burns, David
    Salmenniemi, Urpu
    Rambaldi, Alessandro
    Choi, Goda
    de Latour, Regis Peffault
    Vydra, Jan
    Sengeloev, Henrik
    Eder, Matthias
    Mielke, Stephan
    Forcade, Edouard
    Bondarenko, Sergey
    Ciceri, Fabio
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2024, 59 : 23 - 24
  • [38] The Role of Post-Remission Chemotherapy before T-Cell Depleted Allogeneic Stem Cell Transplant for Acute Myeloid Leukemia in First Complete Remission
    Assal, Amer
    Jakubowski, Ann A.
    Maloy, Molly
    Zheng, Junting
    Devlin, Sean M.
    Avecilla, Scott
    Barker, Juliet N.
    Castro-Malaspina, Hugo
    Dahi, Parastoo
    Gyurkocza, Boglarka
    Meagher, Richard
    Perales, Miguel-Angel
    Shaffer, Brian
    Tamari, Roni
    Young, James W.
    Giralt, Sergio A.
    Papadopoulos, Esperanza B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S197 - S198
  • [39] Prognostic Impact of Clonal Hematopoiesis in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation in Complete Remission
    Grimm, Juliane B. I. J.
    Bill, Marius
    Jentzsch, Madlen
    Beinicke, Stefanie
    Hantschel, Janine
    Goldmann, Karoline
    Schulz, Julia
    Cross, Michael
    Ponisch, Wolfram
    Vucinic, Vladan
    Behre, Gerhard
    Lange, Thoralf
    Franke, Georg-Nikolaus
    Niederwieser, Dietger
    Schwind, Sebastian
    BLOOD, 2017, 130
  • [40] Allogeneic hemopoletic stem cell transplantation for acute myeloid leukemia in first complete remission - Low transplant mortality despite increasing age
    di Grazia, C
    van Lint, M
    Dominietto, A
    Raiola, A
    Lamparelli, T
    Gualandi, F
    Occhini, D
    Bregante, S
    Fiorone, M
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2002, 29 : S81 - S81
12345